Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule”... View Details
Keywords: Sean Silverthorne
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on our research, we believe the... View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
you are saving lives. So it has to have a humanitarian angle to it." (Cipla manufactures generic versions of a number of commonly prescribed medicines and is the world's largest manufacturer of the antiretroviral drugs that fight HIV and... View Details
Keywords: by Julia Hanna
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of drug... View Details
Keywords: by Julia Hanna
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 03 Apr 2007
- First Look
First Look: April 3, 2007
drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and (2) institute numerical metrics—jointly affecting all R&D... View Details
Keywords: Martha Lagace
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Although Novartis would improve its position in oncology by acquiring GSK’s promising drug portfolio, it had to sell its vaccines and animal health businesses, while giving up control of the over-the-counter (OTC) business. Jimenez and... View Details
Keywords: Carmen Nobel
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
commercialization of important new drugs to the detriment of consumers. Interestingly, though, at public hearings, the AstraZeneca chief executive championed the interests of patients in opposing the proposed merger. Consumers worldwide... View Details
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
programs to an investment board comprising both insiders (senior GSK executives) and outsiders (including a venture capitalist and a biotech CEO). After a three-month review period, successful teams are awarded three years worth of investment funding. Because View Details
Keywords: by Carmen Nobel
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,... View Details
Keywords: Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from... View Details
Keywords: Martha Lagace
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
"Transforming Life, Transforming Business: The Life-Science Revolution," a McKinsey Award-winning article he coauthored in the March-April 2000 issue of Harvard Business Review. "As distinctions between food and medicine fade, we will see a proliferation... View Details
- 15 Apr 2008
- First Look
First Look: April 15, 2008
destructive behaviors such as cutting, excessive use of alcohol, taking drugs and suicide attempts. These patients are very difficult to treat and TBC has developed programs that make a noticeable difference to these patients. DBT... View Details
Keywords: Martha Lagace
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped... View Details
Keywords: Martha Lagace
- 17 Nov 2008
- Research & Ideas
Decoding the Artful Sidestep
There are two findings that we find most interesting. First, it is striking that participants failed to punish the speaker when he dodged the question asked. For example, the speaker paid no price for answering a question about the illegal View Details
Keywords: by Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
information standards in accounting (through the Financial Accounting Standards Board) and in food labeling (through the Food and Drug Administration). There are likely lessons for both regulatory agencies in such a comparative analysis. View Details
Keywords: by Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 11 May 2010
- First Look
First Look: May 11
rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards View Details
Keywords: Martha Lagace
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and... View Details